You are here

  • Home
  • Archive
  • Volume 82, Issue Suppl 1
  • AB0199 THE PROGNOSTIC VALUE OF IGA ANTI-CITRULLINATED PROTEIN ANTIBODY AND RHEUMATOID FACTOR IN AN EARLY ARTHRITIS COHORT WITH A TREAT-TO-TARGET APPROACH

Citation Tools

Article menu

Download PDFPDF

Scientific Abstracts
Publication only
Rheumatoid arthritis - prognosis, predictors and outcome
AB0199 THE PROGNOSTIC VALUE OF IGA ANTI-CITRULLINATED PROTEIN ANTIBODY AND RHEUMATOID FACTOR IN AN EARLY ARTHRITIS COHORT WITH A TREAT-TO-TARGET APPROACH
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Heutz J, Schreurs MW, Van der Helm – van Mil A, et al
AB0199 THE PROGNOSTIC VALUE OF IGA ANTI-CITRULLINATED PROTEIN ANTIBODY AND RHEUMATOID FACTOR IN AN EARLY ARTHRITIS COHORT WITH A TREAT-TO-TARGET APPROACH
Annals of the Rheumatic Diseases 2023;82:1282-1283.